Stock DIGN DIGNITANA AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Dignitana AB

Equities

DIGN

SE0002108001

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:54 2024-04-26 am EDT 		5-day change 1st Jan Change
1.54 SEK -8.06% Intraday chart for Dignitana AB -6.67% -29.36%
Apr. 24 Dignitana AB Announces Chief Executive Officer Changes , Effective May 2, 2024 CI
Apr. 04 Dignitana Raises SEK19 Million via Rights Issue of Shares MT

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • Low profitability weakens the company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
DIGNITANA AB Stock Dignitana AB
-29.36% 10.82M -
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+73.17% 12.34B
B-
PENUMBRA, INC. Stock Penumbra, Inc.
-18.74% 7.96B
C+
MASIMO CORPORATION Stock Masimo Corporation
+16.15% 7.16B
C-
GETINGE AB Stock Getinge AB
+4.81% 5.72B
B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+5.99% 5.03B
D+
APT MEDICAL INC. Stock APT Medical Inc.
+27.07% 4.35B -
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-21.67% 3.99B
B-
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-40.82% 2.21B
C
SKAN GROUP AG Stock SKAN Group AG
+1.49% 2.01B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. DIGN Stock
  4. Ratings Dignitana AB